Clearstead Advisors’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.7K | Hold |
6,000
| – | – | ﹤0.01% | 1799 |
|
|
2025
Q1 | $7.32K | Hold |
6,000
| – | – | ﹤0.01% | 1682 |
|
|
2024
Q4 | $7.74K | Buy |
6,000
+3,000
| +100% | +$3.87K | ﹤0.01% | 1636 |
|
|
2024
Q3 | $8.25K | Hold |
3,000
| – | – | ﹤0.01% | 1617 |
|
|
2024
Q2 | $6.78K | Hold |
3,000
| – | – | ﹤0.01% | 1626 |
|
|
2024
Q1 | $9.24K | Hold |
3,000
| – | – | ﹤0.01% | 1064 |
|
|
2023
Q4 | $4.98K | Sell |
3,000
-3,000
| -50% | -$4.98K | ﹤0.01% | 1161 |
|
|
2023
Q3 | $11.5K | Buy |
6,000
+4,500
| +300% | +$8.64K | ﹤0.01% | 1099 |
|
|
2023
Q2 | $2.16K | Buy |
+1,500
| New | +$2.16K | ﹤0.01% | 1132 |
|